ACM
TECX

Aisling Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Aisling Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-84,148
Closed -$2.55M – 16
2024
Q3 		$2.55M Hold
84,148
– – 0.98% 10
2024
Q2 		$1.39M Hold
84,148
– – 0.6% 12
2024
Q1 		$1.29M Hold
84,148
– – 0.44% 13
2023
Q4 		$1.37M Hold
84,148
– – 0.41% 13
2023
Q3 		$1.56M Hold
84,148
– – 0.64% 13
2023
Q2 		$959K Hold
84,148
– – 0.47% 13
2023
Q1 		$1.01M Hold
84,148
– – 0.49% 12
2022
Q4 		$717K Hold
84,148
– – 0.47% 14
2022
Q3 		$646K Hold
84,148
– – 0.43% 15
2022
Q2 		$929K Hold
84,148
– – 0.66% 15
2022
Q1 		$1.33M Hold
84,148
– – 0.72% 17
2021
Q4 		$3.89M Hold
84,148
– – 1.37% 15
2021
Q3 		$5.63M Hold
84,148
– – 1.12% 15
2021
Q2 		$8.98M Hold
84,148
– – 1.44% 13
2021
Q1 		$12.8M Hold
84,148
– – 2.31% 8
2020
Q4 		$14.1M Hold
84,148
– – 2.42% 6
2020
Q3 		$13.1M Hold
84,148
– – 4.2% 5
2020
Q2 		$17.6M Hold
84,148
– – 6.72% 3
2020
Q1 		$15.7M Buy
84,148
+9,725
+13% +$2.29M 6.84% 3
2019
Q4 		$18M Hold
74,423
– – 6.89% 3
2019
Q3 		$12.6M Buy
74,423
+6,756
+10% +$1.53M 6.57% 3
2019
Q2 		$13.2M Hold
67,667
– – 5.64% 5
2019
Q1 		$17.9M Buy
67,667
+6,250
+10% +$1.14M 13.64% 2
2018
Q4 		$12.3M Buy
+61,417
New +$18.7M 12.93% 3

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Aisling Capital Management's TECX Position: Q4 2024 in Review

Aisling Capital Management sold out of Tectonic Therapeutic (TECX) in Q4 2024, closing a stake of 84,148 shares — an estimated $2.55M sold.

Aisling Capital Management first reported a position in TECX in Q4 2018 and held it in 24 quarters. The position peaked at $18M in Q4 2019. 70 funds tracked by Wall St. Rank hold TECX as of Q4 2024.

  • Aisling Capital Management reported no remaining Tectonic Therapeutic position as of Q4 2024 after selling out during the quarter.
  • Aisling Capital Management sold 84,148 Tectonic Therapeutic shares in Q4 2024, an estimated $2.55M.
  • Aisling Capital Management first reported a position in Tectonic Therapeutic in Q4 2018 and held it in 24 quarters.
  • Aisling Capital Management's Tectonic Therapeutic position peaked at $18M in Q4 2019.
  • 70 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2024.

Based on Aisling Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.